Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century.

J Hematol Oncol · 2013 · PMC3848850 · PMID 24499592

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a trend towards higher survival for younger patients (15–39 years old) in Germany, although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.